Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. 2004

Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, USA.

Kaposi sarcoma (KS) is the most common AIDS-associated malignancy and is characterized by angiogenesis and the presence of spindle cells. Kaposi sarcoma-associated herpesvirus (KSHV) is consistently associated with all clinical forms of KS, and in vitro infection of dermal microvascular endothelial cells (DMVECs) with KSHV recapitulates many of the features of KS, including transformation, spindle cell proliferation, and angiogenesis. To study the molecular mechanisms of KSHV pathogenesis, we compared the protein expression profiles of KSHV-infected and uninfected DMVECs. This comparison revealed that heme oxygenase-1 (HO-1), the inducible enzyme responsible for the rate-limiting step in heme catabolism, was up-regulated in infected endothelial cells. Recent evidence suggests that the products of heme catabolism have important roles in endothelial cell biology, including apoptosis and angiogenesis. Here we show that HO-1 mRNA and protein are up-regulated in KSHV-infected cultures. Comparison of oral and cutaneous AIDS-KS tissues with normal tissues revealed that HO-1 mRNA and protein were also up-regulated in vivo. Increased HO-1 enzymatic activity in vitro enhanced proliferation of KSHV-infected DMVECs in the presence of free heme. Treatment with the HO-1 inhibitor chromium mesoporphyrin IX abolished heme-induced proliferation. These data suggest that HO-1 is a potential therapeutic target for KS that warrants further study.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006418 Heme The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. Ferroprotoporphyrin,Protoheme,Haem,Heme b,Protoheme IX
D006419 Heme Oxygenase (Decyclizing) A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. Haem Oxygenase,Heme Oxygenase,Oxygenase, Haem,Oxygenase, Heme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
February 2005, The Journal of infectious diseases,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
March 2020, Trends in microbiology,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
August 2004, Blood,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
March 2006, The Journal of infectious diseases,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
June 2013, Current opinion in virology,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
March 2010, Cancer letters,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
May 2012, Cancer letters,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
December 2020, Romanian journal of internal medicine = Revue roumaine de medecine interne,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
January 2002, Blood,
Shane C McAllister, and Scott G Hansen, and Rebecca A Ruhl, and Camilo M Raggo, and Victor R DeFilippis, and Deborah Greenspan, and Klaus Früh, and Ashlee V Moses
November 2003, Virology,
Copied contents to your clipboard!